Header Logo

KEITH WEBSTER

TitleAdjunct Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Ophthalmology
Address6565 Fannin, NC 205
Houston, TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Waduge P, Tian H, Webster KA, Li W. Profiling disease-selective drug targets: From proteomics to ligandomics. Drug Discov Today. 2023 03; 28(3):103430. PMID: 36343915; PMCID: PMC9974940.
      Citations:    
    2. Irion CI, Williams M, Capcha JC, Eisenberg T, Lambert G, Takeuchi LM, Seo G, Yousefi K, Kanashiro-Takeuchi R, Webster KA, Young KC, Hare JM, Shehadeh LA. Col4a3-/- Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 Backgrounds. Int J Mol Sci. 2022 Jun 15; 23(12). PMID: 35743114; PMCID: PMC9223785.
      Citations:    Fields:    Translation:Animals
    3. Dai C, Tian H, Bhatt A, Su G, Webster KA, Li W. Safety and Efficacy of Systemic Anti-Scg3 Therapy to Treat Oxygen-Induced Retinopathy. Front Biosci (Landmark Ed). 2022 04 19; 27(4):130. PMID: 35468689; PMCID: PMC9201993.
      Citations:    Fields:    Translation:HumansAnimals
    4. Dai C, Waduge P, Ji L, Huang C, He Y, Tian H, Zuniga-Sanchez E, Bhatt A, Pang IH, Su G, Webster KA, Li W. Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy. Cell Mol Life Sci. 2022 Jan 10; 79(1):63. PMID: 35006382; PMCID: PMC9007175.
      Citations: 3     Fields:    Translation:Animals
    5. Ji L, Waduge P, Hao L, Kaur A, Wan W, Wu Y, Tian H, Zhang J, Webster KA, Li W. Selectively targeting disease-restricted secretogranin III to alleviate choroidal neovascularization. FASEB J. 2022 01; 36(1):e22106. PMID: 34918375; PMCID: PMC8694659.
      Citations: 3     Fields:    Translation:AnimalsCells
    6. He Y, Tian H, Dai C, Wen R, Li X, Webster KA, Li W. Optimal Efficacy and Safety of Humanized Anti-Scg3 Antibody to Alleviate Oxygen-Induced Retinopathy. Int J Mol Sci. 2021 Dec 29; 23(1). PMID: 35008775; PMCID: PMC8745183.
      Citations:    Fields:    Translation:HumansAnimalsCells
    7. Ji L, Tian H, Webster KA, Li W. Neurovascular regulation in diabetic retinopathy and emerging therapies. Cell Mol Life Sci. 2021 Aug; 78(16):5977-5985. PMID: 34230991; PMCID: PMC8602033.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    8. Dai C, Webster KA, Bhatt A, Tian H, Su G, Li W. Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies. Int J Mol Sci. 2021 May 01; 22(9). PMID: 34062733; PMCID: PMC8124946.
      Citations: 7     Fields:    Translation:HumansAnimals
    9. Li W, Webster KA, LeBlanc ME, Tian H. Secretogranin III: a diabetic retinopathy-selective angiogenic factor. Cell Mol Life Sci. 2018 02; 75(4):635-647. PMID: 28856381; PMCID: PMC5771826.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    10. Wang W, LeBlanc ME, Chen X, Chen P, Ji Y, Brewer M, Tian H, Spring SR, Webster KA, Li W. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease. Angiogenesis. 2017 Nov; 20(4):479-492. PMID: 28447229; PMCID: PMC5658272.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    11. Hu X, Chen P, Wu Y, Wang K, Xu Y, Chen H, Zhang L, Wu R, Webster KA, Yu H, Zhu W, Wang J. MiR-211/STAT5A Signaling Modulates Migration of Mesenchymal Stem Cells to Improve its Therapeutic Efficacy. Stem Cells. 2016 07; 34(7):1846-58. PMID: 27145179; PMCID: PMC5096301.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    12. Hu X, Zhang L, Jin J, Zhu W, Xu Y, Wu Y, Wang Y, Chen H, Webster KA, Chen H, Yu H, Wang J. Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis. Stem Cells. 2015 Jun; 33(6):1850-1862. PMID: 25754303; PMCID: PMC5108061.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    13. LeBlanc ME, Wang W, Caberoy NB, Chen X, Guo F, Alvarado G, Shen C, Wang F, Wang H, Chen R, Liu ZJ, Webster K, Li W. Hepatoma-derived growth factor-related protein-3 is a novel angiogenic factor. PLoS One. 2015; 10(5):e0127904. PMID: 25996149; PMCID: PMC4440747.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    14. Hu X, Wu R, Jiang Z, Wang L, Chen P, Zhang L, Yang L, Wu Y, Chen H, Chen H, Xu Y, Zhou Y, Huang X, Webster KA, Yu H, Wang J. Leptin signaling is required for augmented therapeutic properties of mesenchymal stem cells conferred by hypoxia preconditioning. Stem Cells. 2014 Oct; 32(10):2702-13. PMID: 24989835; PMCID: PMC5096299.
      Citations: 35     Fields:    Translation:HumansAnimalsCells
    15. Zhou MS, Chadipiralla K, Mendez AJ, Jaimes EA, Silverstein RL, Webster K, Raij L. Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling. Am J Physiol Heart Circ Physiol. 2013 Aug 15; 305(4):H563-74. PMID: 23748423; PMCID: PMC3891251.
      Citations: 25     Fields:    Translation:HumansAnimalsCells
    16. Shao H, Xu Q, Wu Q, Ma Q, Salgueiro L, Wang J, Eton D, Webster KA, Yu H. Defective CXCR4 expression in aged bone marrow cells impairs vascular regeneration. J Cell Mol Med. 2011 Oct; 15(10):2046-56. PMID: 21143386; PMCID: PMC3076550.
      Citations: 18     Fields:    Translation:AnimalsCells
    17. Song X, Ma Q, Liu X, Seo P, Herderick E, Webster K, Goldschmidt-Clermont PJ, Seo D. Will periodic intravenous injections of conditioned bone marrow cells effectively reduce atherosclerosis? Antioxid Redox Signal. 2012 Jan 01; 16(1):85-91. PMID: 21740335; PMCID: PMC3218380.
      Citations: 3     Fields:    Translation:Animals
    18. Cho HM, Rosenblatt JD, Kang YS, Iruela-Arispe ML, Morrison SL, Penichet ML, Kwon YG, Kim TW, Webster KA, Nechustan H, Shin SU. Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein. Mol Cancer Ther. 2005 Jun; 4(6):956-67. PMID: 15956253.
      Citations: 9     Fields:    Translation:HumansAnimalsCells
    19. Dougherty CJ, Kubasiak LA, Frazier DP, Li H, Xiong WC, Bishopric NH, Webster KA. Mitochondrial signals initiate the activation of c-Jun N-terminal kinase (JNK) by hypoxia-reoxygenation. FASEB J. 2004 Jul; 18(10):1060-70. PMID: 15226266.
      Citations: 38     Fields:    Translation:AnimalsCells
    WEBSTER's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (147)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _